<DOC>
	<DOCNO>NCT02579408</DOCNO>
	<brief_summary>Non-alcoholic fatty liver disease common chronic liver disease Hong Kong . Its presence among donor live donor liver transplant could affect outcome recipient liver transplantation . By use control attenuation parameter ( CAP ) measurement , investigator aim investigate association CAP measurement severity fatty liver among liver donor recipient outcomes live donor liver transplantation .</brief_summary>
	<brief_title>Quantifying Steatosis Liver Transplant Donors</brief_title>
	<detailed_description>Living donor liver transplantation ( LDLT ) increase worldwide due critical shortage cadaveric donor rise number patient await liver transplantation . The long-term survival rate LDLT comparable decease donor liver transplantation . Currently , two-thirds liver transplant perform Hong Kong LDLT . The ultimate goal LDLT guarantee donor safety optimize best possible recipient outcome . Donor liver steatosis well-known factor could influence graft function long-term outcome recipient allograft , also affect donor hepatic recovery . When need , pre-operative liver biopsy often use quantitative assessment donor steatosis , LDLT recommend steatosis exceeds 30 % . Nonetheless , liver biopsy limit invasive nature , sample error intra-observer variation . Imaging evaluation quantification steatosis via ultrasonography compute tomography also various pitfall . There currently universal consensus ideal method assess donor steatosis . Controlled attenuation parameter ( CAP ) novel non-invasive method quantify hepatic steatosis use ultrasonic attenuation postulate fat content . It demonstrate good correlation degree hepatic steatosis Western Asian population . The investigator aim evaluate application CAP donor workup LDLT investigate association post-transplant outcome .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Age 1860 LDLT donor complete donor workup Consents study entry Concomitant liver disease , include chronic hepatitis B C infection , autoimmune hepatitis , primary biliary cirrhosis , primary sclerosing cholangitis , Wilson disease , increase alcohol intake ( 30g per week male , 20g per week female ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>LDLT</keyword>
	<keyword>steatosis</keyword>
	<keyword>CAP</keyword>
	<keyword>transient elastography</keyword>
</DOC>